XVIVO Scientific Animation recently wrapped up an exciting project on the bacteria that are found in the human mouth and how these bacteria are affected by oral hygiene (or the lack thereof). We teamed up again with colleagues at Johnson & Johnson for a new virtual reality (VR) visualization of the normal bacterial community that …
Start-up with Style: Launch your Visuals with XVIVO
By
Michael Astrachan
As the saying goes, a picture is worth a thousand words. Start-up pharmaceutical and biotech companies often need to create illustrations, investigational candidate images, and animations to provide rich scientific detail on a disease state, a process, or a mechanism of action for their website, for presentations, and for printed materials. XVIVO Scientific Animation is …
Illustrating the Unconventional: PROTAC™ Technology for Disease Therapy
By
Michael Astrachan
XVIVO, in collaboration with Wyant Simboli and their client, Arvinas Inc., helped communicate the unconventional mechanism of action for a new class of drugs that engage the body’s own protein disposal system to target cancers and other difficult-to-treat diseases. PROTAC™ PLATFORM Arvinas’ approach is to tag a protein implicated in a disease with their proprietary Proteolysis-Targeting Chimera, …
XVIVO Founder on UCONN VR Panel
By
Michael Astrachan
This week, XVIVO’s Founder and Creative Director, Michael Astrachan, spoke on an invited panel of guests at UCONN’s Science Salon to discuss “Seeing Things: Virtual Reality Hits Mainstream.” Michael was honored to speak alongside the other accomplished panelists: Patrick Belinger, Creator of NovaSwarm; Horea Ilies, Professor of Mechanical Engineering at UCONN; and Zach Stone, Vice …
New Year, New Reel
By
Michael Astrachan
To kick-off the New Year, we’re launching a fresh new showreel for XVIVO. 2018 was an exciting and rewarding year for the team at XVIVO Scientific Animation. We delved into new topics, such as neuroendocrine tumors and ciliary motility, we expanded our capabilities in virtual reality and interactive experiences, and we completed hundreds of projects …
XVIVO Cheer
By
Michael Astrachan
XVIVO is in the holiday spirit! This past Saturday, the team at XVIVO got the opportunity to relax, unwind and celebrate another successful year together. Our team looked dapper and dressed up for the holiday season! Here are some of the highlights from this year’s XVIVO Holiday Party! Our audio director, Matt Berky, was under …
Phase Change Memory Illustrated
By
Michael Astrachan
Phase Change Memory illustration An XVIVO illustration graces the August 2018 journal cover of Nature Materials and is also currently featured on their home page. XVIVO partnered with researchers at RWTH Aachen University in Germany to help visualize the results of their recent studies, which were published in Nature Materials. The researchers were trying to improve on existing methods and devices …
Hidden Signals: Animating Advanced ECG Analysis
By
Michael Astrachan
Chances are you know someone who has coronary heart disease (CHD). An estimated 16.5 million adults in American have CHD. And it is the leading cause of death in men and women, attributed to 1 of every 7 deaths in the United States. CHD occurs when cholesterol and plaque buildup on the inside of the arteries that supply blood …
How Do Cilia and Flagella Move?
By
Michael Astrachan
The XVIVO team is proud of a recent project in collaboration with Dr. Daniela Nicastro , Associate Professor at the University of Texas Southwestern Medical Center. Dr. Nicastro and her research colleagues had completed some complex and ground-breaking research into how cilia and flagella generate their whip-like motion, and they asked XVIVO to help them visualize the …
Being There: Virtual Reality in Medical Animation
By
Michael Astrachan
The team at XVIVO Scientific Animation is hitting the road to showcase their newest capabilities in virtual reality (VR) for interactive medical visualizations. In the latest fully-interactive experience they’ve developed, running on an Oculus Rift, you are a drug delivery agent who is miniaturized and inserted into a cell. Once in the cell, your job …